Antidiabetic Drug Utilization in Hungary

Author： Hankó Balázs   Tukarcs Éva   Kumli Péter   Vincze Zoltán  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.27, Iss.3, 2005-06, pp. : 263-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo antidiabetic drug discovery

By Luo J.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 6, 1998-06 ,pp. : 987-996

Informa Healthcare

Access to resources Recommend Favorite

Incidence of potential drug-drug interactions with antidiabetic drugs

By Samardzic I.   Bacic-Vrca V.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 6, 2015-06 ,pp. : 410-415

Govi-Verlag

Access to resources Recommend Favorite

A study on ethosomes as mode for transdermal delivery of an antidiabetic drug

By Bodade Siddhodhan S.   Shaikh Karimunnisa Sameer   Kamble Meghana S.   Chaudhari Praveen D.  

Drug Delivery, Vol. 20, Iss. 1, 2013-08 ,pp. : 40-46

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects

By Pfützner Andreas   Weber Matthias M   Forst Thomas  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1985-1998

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality

By Pfützner Andreas   Forst Thomas  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 463-476

Informa Healthcare

Access to resources Recommend Favorite